Martin Lehr
Gründer bei CONTEXT THERAPEUTICS INC.
Vermögen: 1 Mio $ am 30.04.2024
Aktive Positionen von Martin Lehr
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CONTEXT THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 01.04.2015 | - |
| Vorstandsvorsitzender | 01.04.2015 | - | |
| Gründer | 01.04.2015 | - | |
| Präsident | 01.04.2015 | - | |
Context Therapeutics LLC
 Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA. | Direktor/Vorstandsmitglied | 01.01.2016 | - |
| Vorstandsvorsitzender | 01.01.2016 | - | |
| Gründer | 01.01.2016 | - | |
| The Biobreak Organization, Inc. | Direktor/Vorstandsmitglied | 01.01.2009 | - |
Praesidia Biotherapeutics, Inc.
 Praesidia Biotherapeutics, Inc. Medical/Nursing ServicesHealth Services Praesidia Biotherapeutics, Inc. is a company that specializes in developing drugs using their proprietary Tunable Linker Technology called LESS (Linker Enzyme Substrate System). The company is based in Arlington, MA. This technology helps to maximize the therapeutic potential of drugs. The company was founded by Sohang Chatterjee, Pradip K. Majumder, and Santosh Kesari, with Sohang Chatterjee serving as the CEO since incorporation. | Direktor/Vorstandsmitglied | 01.11.2020 | - |
| Independent Dir/Board Member | 01.11.2020 | - | |
CureDuchenne Ventures LLC
 CureDuchenne Ventures LLC Investment ManagersFinance CureDuchenne Ventures LLC (CureDuchenne Ventures) is a venture capital subsidiary of CureDuchenne, founded in 2014 by Debra Miller. The firm is headquartered in Newport Beach, California. | Direktor/Vorstandsmitglied | 01.05.2019 | - |
Karriereverlauf von Martin Lehr
Ehemalige bekannte Positionen von Martin Lehr
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
OUP Management Co. LLC
 OUP Management Co. LLC Investment ManagersFinance OUP Management Co. LLC (Osage Partners) is a venture capital firm founded by Robert Adelson and Louis Berneman in 1990. The firm is headquartered in Bala Cynwyd, Pennsylvania. | Private-Equity-Analyst | 13.08.2009 | - |
Ausbildung von Martin Lehr
| The Trustees of Columbia University in The City of New York | Graduate Degree |
| University of Pennsylvania | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 9 |
Operativ
| Director/Board Member | 5 |
| Chief Executive Officer | 2 |
| Founder | 2 |
Sektoral
| Finance | 3 |
| Consumer Services | 3 |
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CONTEXT THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
OUP Management Co. LLC
OUP Management Co. LLC Investment ManagersFinance OUP Management Co. LLC (Osage Partners) is a venture capital firm founded by Robert Adelson and Louis Berneman in 1990. The firm is headquartered in Bala Cynwyd, Pennsylvania. | Finance |
Context Therapeutics LLC
Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA. | Health Technology |
| The Biobreak Organization, Inc. | |
Praesidia Biotherapeutics, Inc.
Praesidia Biotherapeutics, Inc. Medical/Nursing ServicesHealth Services Praesidia Biotherapeutics, Inc. is a company that specializes in developing drugs using their proprietary Tunable Linker Technology called LESS (Linker Enzyme Substrate System). The company is based in Arlington, MA. This technology helps to maximize the therapeutic potential of drugs. The company was founded by Sohang Chatterjee, Pradip K. Majumder, and Santosh Kesari, with Sohang Chatterjee serving as the CEO since incorporation. | Health Services |
CureDuchenne Ventures LLC
CureDuchenne Ventures LLC Investment ManagersFinance CureDuchenne Ventures LLC (CureDuchenne Ventures) is a venture capital subsidiary of CureDuchenne, founded in 2014 by Debra Miller. The firm is headquartered in Newport Beach, California. | Finance |
- Börse
- Insiders
- Martin Lehr
- Erfahrung
